share_log

Pliant Therapeutics Q4 2023 GAAP EPS $(0.69) Beats $(0.82) Estimate

Moomoo 24/7 ·  Feb 27 17:18

Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.82) by 15.85 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment